BERSANI, Samantha
 Distribuzione geografica
Continente #
EU - Europa 2.817
NA - Nord America 2.510
AS - Asia 1.618
SA - Sud America 232
AF - Africa 53
OC - Oceania 5
Totale 7.235
Nazione #
US - Stati Uniti d'America 2.436
RU - Federazione Russa 991
SG - Singapore 641
GB - Regno Unito 556
IT - Italia 468
CN - Cina 466
BR - Brasile 188
DE - Germania 158
HK - Hong Kong 156
VN - Vietnam 147
SE - Svezia 124
FI - Finlandia 104
FR - Francia 102
IE - Irlanda 91
NL - Olanda 68
KR - Corea 45
CA - Canada 40
IN - India 33
AT - Austria 28
ES - Italia 28
UA - Ucraina 26
JP - Giappone 24
MX - Messico 22
IQ - Iraq 19
AR - Argentina 16
BD - Bangladesh 14
BE - Belgio 14
NG - Nigeria 14
PL - Polonia 13
TR - Turchia 13
ID - Indonesia 12
TG - Togo 12
CZ - Repubblica Ceca 8
UZ - Uzbekistan 8
CH - Svizzera 7
CL - Cile 7
MA - Marocco 7
VE - Venezuela 7
BJ - Benin 6
JO - Giordania 6
AU - Australia 5
CO - Colombia 5
LT - Lituania 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
IR - Iran 4
PY - Paraguay 4
AL - Albania 3
CR - Costa Rica 3
HR - Croazia 3
KG - Kirghizistan 3
PH - Filippine 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
DZ - Algeria 2
EC - Ecuador 2
GE - Georgia 2
GR - Grecia 2
KE - Kenya 2
KZ - Kazakistan 2
PK - Pakistan 2
SI - Slovenia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 7.235
Città #
Southend 462
Dallas 363
Singapore 362
Moscow 350
Ashburn 279
San Jose 225
Chandler 211
Hong Kong 153
Jacksonville 144
Verona 136
Ann Arbor 130
Woodbridge 101
Beijing 100
Dublin 85
The Dalles 68
New York 64
Council Bluffs 63
Houston 56
Munich 56
Los Angeles 49
Hanoi 43
Ho Chi Minh City 40
Helsinki 39
Shenyang 29
Lawrence 27
Princeton 27
Buffalo 25
Nanjing 25
Madrid 24
Changsha 22
Wilmington 22
Rome 21
Santa Clara 21
Tokyo 20
Hebei 19
Jinan 18
London 18
Orem 18
Tianjin 17
Guangzhou 16
São Paulo 16
Brescia 15
Frankfurt am Main 15
Milan 15
Vienna 15
Abuja 14
Brussels 14
Denver 14
Montreal 13
Ningbo 13
Redondo Beach 13
Turku 13
Warsaw 13
Boardman 12
Lomé 12
Stockholm 12
Amsterdam 10
Mexico City 10
Nuremberg 10
Sindelfingen 10
Bologna 9
Columbus 9
Brooklyn 8
Chennai 8
Dearborn 8
Fuzhou 8
Haikou 8
Lappeenranta 8
Paris 8
Poplar 8
Shanghai 8
Toronto 8
Zhengzhou 8
Chicago 7
Ankara 6
Baghdad 6
Barnet 6
Cotonou 6
Manchester 6
Piscataway 6
Redmond 6
Seattle 6
Seoul 6
Taizhou 6
Tashkent 6
Belo Horizonte 5
Boston 5
Brno 5
Curitiba 5
Falkenstein 5
Kyiv 5
Nanchang 5
Newark 5
Norwalk 5
Salvador 5
San Francisco 5
Amman 4
Aparecida de Goiânia 4
Auburn Hills 4
Augusta 4
Totale 4.457
Nome #
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 372
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 285
Whole-genome landscape of pancreatic neuroendocrine tumours 280
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival 258
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene terapy 231
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 226
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models 214
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene therapy 211
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 207
Chromosome 3p alterations in pancreatic endocrine neoplasia 204
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 203
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 192
Reporting tumor molecular heterogeneity in histopathological diagnosis 190
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 185
Molecular characterization of Pancreatic NeuroEndocrine Tumors (PanNETs) 184
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 181
Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies 178
Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses 176
Genotypic Intratumoral Heterogeneity in Breast Carcinoma with HER2/neu Amplification Evaluation According to ASCO/CAP Criteria 175
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns 170
Divergent mutational processes distinguish hypoxic and normoxic tumours 169
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 168
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy 162
Author Correction: The landscape of viral associations in human cancers 159
Suitability of infiltrative lobular breast carcinoma for anti-human epidermal growth factor receptor 2 treatment after the ASCO/CAP and 2009 St Gallen International Expert Consensus meeting 158
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 158
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior 153
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 146
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer 141
Combined burden and functional impact tests for cancer driver discovery using DriverPower 134
Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma 133
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 129
Author Correction: Pan-cancer analysis of whole genomes 129
Comprehensive molecular characterization of mitochondrial genomes in human cancers 124
Integrative pathway enrichment analysis of multivariate omics data 121
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 117
The landscape of viral associations in human cancers 114
FISH Scoring on Paraffin Sections Versus Single-cell Suspension for Chromophobe Renal Carcinoma and Renal Oncocytoma 107
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 105
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size 98
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig 84
Genomic footprints of activated telomere maintenance mechanisms in cancer 84
Inferring structural variant cancer cell fraction 63
High fidelity of Claudin-18.2 expression in primary and matched metastatic (lymph nodes, peritoneum, and liver) pancreatic ductal adenocarcinoma: a foundation for targeted therapy 26
Totale 7.304
Categoria #
all - tutte 21.182
article - articoli 19.458
book - libri 0
conference - conferenze 1.297
curatela - curatele 0
other - altro 427
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 10 24 13
2021/2022277 26 100 14 34 8 4 4 16 6 5 21 39
2022/2023542 43 77 44 87 56 133 3 29 56 0 9 5
2023/2024381 12 15 29 40 22 61 4 51 27 33 64 23
2024/20251.187 59 53 76 156 57 58 91 67 144 78 144 204
2025/20263.384 240 166 348 559 863 221 298 170 316 203 0 0
Totale 7.304